Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments

BACKGROUND: Inhaled corticosteroid/long-acting β(2)-agonist combinations and/or long-acting muscarinic antagonists are recommended first-line therapies for preventing chronic obstructive pulmonary disease (COPD) exacerbation. Comparative effectiveness of budesonide/formoterol combination (BFC, an in...

Descripción completa

Detalles Bibliográficos
Autores principales: Trudo, Frank, Kern, David M, Davis, Jill R, Tunceli, Ozgur, Zhou, Siting, Graham, Emma L, Strange, Charlie, Williams, Setareh A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592033/
https://www.ncbi.nlm.nih.gov/pubmed/26451101
http://dx.doi.org/10.2147/COPD.S90658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592033/
https://www.ncbi.nlm.nih.gov/pubmed/26451101
http://dx.doi.org/10.2147/COPD.S90658

Ejemplares similares